

  











<!doctype html>
<html>
<head>
    <meta charset="utf-8">
    
        <meta name="viewport" content="width=device-width,initial-scale=1">
    
    
    
    
    
    
    
        
            <title>Research Update from the MCM Team (February 2024)</title>
        
        
    
    
    
    
    
        


<meta name="Description" content="World Community Grid enables anyone with a computer, smartphone or tablet to donate their unused computing power to advance cutting-edge scientific research on topics related to health, poverty and sustainability."/>
<meta name="Keywords" content="World Community Grid, Volunteer Computing, Let your computer daydream science"/>










<meta property="og:url" content="https://www.worldcommunitygrid.org/about_us/article.s?articleId=807" />
<meta property="og:type" content="website" />
<meta property="og:locale" content="en_US" />
<meta property="og:title" content="Research Update from the MCM Team (February 2024)" />
<meta property="og:description" content="We continue our work on characterising lung cancer biomarkers identified in the MCM1 project. This update focuses on a transcriptional corepressor TLE3." />
<meta property="og:image" content="https://www.worldcommunitygrid.org/images/prismic/mcm_fullbodied_update.png" />
<meta property="og:image:secure_url" content="https://www.worldcommunitygrid.org/images/prismic/mcm_fullbodied_update.png" />
<meta property="og:image:width" content="676" />
<meta property="og:image:height" content="380" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:site" content="@WCGrid" />
<meta name="twitter:creator" content="@WCGrid" />


    
    
    
    <script>
    var WCG = {};
    WCG.facebook = {};
    WCG.facebook.app_id=112250102148804;
    WCG.locale = {};
    WCG.locale.language='en';
    WCG.locale.country='US';
</script>

    
    
        
<link rel="stylesheet" type="text/css" href="/generated/css/wcg_8ff7f2b046.css" />
<script src="/generated/js/wcg_8a248d7cc7.js"></script>
<script>
	var $j = jQuery.noConflict();
</script>

    
        <link rel="stylesheet" type="text/css" href="/css/lib/jquery-ui-1.11.4/jquery-ui.min.css" />
<link rel="stylesheet" type="text/css" href="/css/lib/jquery-ui-1.11.4/jquery-ui.override.css" />
<script type="text/javascript">
	var $ = $j;
</script>
<script src="/js/lib/jquery-ui-1.11.4/jquery-ui.min.js" ></script>

    
        <script src="/js/lib/jquery.slides.min.js" ></script>
<link rel="stylesheet" type="text/css" href="/css/feature/news-slideshow-styles.css">

    
    
    
    
    
    
    <link href="/static/css/2.7b4bf2a7.chunk.css" rel="stylesheet"/>
<link href="/static/css/main.a189a511.chunk.css" rel="stylesheet"/>

</head>


    <body class="">


    <div class="wcg-legacy-layout wcg-legacy-vertical-flex-container" >
        


    


    

<div id="header" class="header__container" data-context-type="main" data-context-section="" data-context-highlight="News"></div>
        <div id="top" class="wcg-legacy-vertical-flex-item wcg-legacy-vertical-flex-container">
            
            
            <div class="wcg-legacy-vertical-flex-item " >
	            
	            <div class="bx--grid" style="width: 100%">
	                <div class="bx--row">
	                    <div class="bx--col-sm-4 bx--col-md-8 bx--offset-lg-3 bx--col-lg-10 bx--offset-xlg-4 bx--col-xlg-8">

	                    <div class="wcg-legacy wcg-body-padding">
	                        










<main>
    <div id="newsArticleContent" class="news-article">
    <nav class="bx--breadcrumb" aria-label="breadcrumb">
        <div class="bx--breadcrumb-item">
            <a href="/about_us/news.s" class="bx--link" >News</a>
        </div>
    </nav>
    <h1>Research Update from the MCM Team (February 2024)</h1>
	    <article class="middle-article">
	        
		        <br/>
		        <p>We continue our work on characterising lung cancer biomarkers identified in the MCM1 project. This update focuses on a transcriptional corepressor TLE3.</p>
	        
	        <hr/>
	        
			
				<p class="related-items"><span class="related-items-title">Project: </span>
				  
				  <a class="related-items-link" href="/research/mcm1/overview.do">Mapping Cancer Markers</a>
				</p>
			
	        
	        <p class="related-items"><span class="related-items-title">Published on: </span>16 Feb 2024</p>
	        <hr style="margin-top:15px;"/>
	        <section>
	            <span><p><strong>Terminology</strong></p>

<p style="list-style-type: disc;"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-style: normal;"><span style="text-decoration: none;"><strong>- Transcription factor: </strong></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">A protein that binds to DNA to control the rate at which DNA is transcribed to messenger RNA.</span></span></span></span></span></span></p>

<p style="list-style-type:disc"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-style: normal;"><span style="text-decoration: none;"><strong>- Trancriptional corepressor: </strong></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">A protein that indirectly represses expression of genes by binding to transcription factors.</span></span></span></span></span></span></p>

<p style="list-style-type:disc"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-style: normal;"><span style="text-decoration: none;"><strong>- Sheehan&#39;s syndrome: </strong></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Postpartum anterior pituitary hormone deficiency due to necrosis of the pituitary gland. This is usually the result of massive hemorrhage during or after delivery.</span></span></span></span></span></span></p>

<p style="line-height:1.38"><strong>Background</strong></p>

<p style="line-height:1.38"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Identifying molecular markers and their combination (signatures) enables us to detect disease earlier (diagnostic signatures) and stratify patients into subgroups based on disease progression patterns (prognostic signatures), potentially leading to identifying which patients may benefit from what treatment (predictive signatures). The Mapping Cancer Markers project analyzes data sets with millions of data points collected from patients with cancers and sarcomas to find such diagnostic, prognostic and predictive signatures.</span></span></span></span></span></span></p>

<p style="line-height:1.38"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Since November 2013, World Community Grid volunteers have donated over 887,100 CPU years to the project, helping analyse data on lung and ovarian cancer and sarcoma, much more thoroughly than otherwise possible. We are immensely grateful for this continued support.</span></span></span></span></span></span></p>

<p style="line-height:1.38"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Further characterising the 26 top-scoring genes in lung cancer, we have already discussed <a href="https://www.worldcommunitygrid.org/about_us/article.s?articleId=782">VAMP1</a>, <a href="https://www.worldcommunitygrid.org/about_us/article.s?articleId=794">FARP1</a>, <a href="https://www.worldcommunitygrid.org/about_us/article.s?articleId=797">GSDMB</a></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">, <a href="https://www.worldcommunitygrid.org/about_us/article.s?articleId=800">ADH6</a></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">, <a href="https://www.worldcommunitygrid.org/about_us/article.s?articleId=804">IL13RA1</a></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">, and <a href="https://www.worldcommunitygrid.org/about_us/article.s?articleId=805">PCSK5</a> </span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">in previous MCM updates. Here, we outline information on TLE3.</span></span></span></span></span></span></p>

<p style="line-height:1.38"><strong>TLE3 Research</strong></p>

<p style="line-height:1.38"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">TLE3 encodes a protein called transducin-like enhancer protein 3, which is a transcriptional corepressor that binds to several transcription factors (<a href="https://www.uniprot.org/uniprotkb/Q04726/entry">Uniprot</a></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">). TLE3 has been implicated in immune functions. Studies have suggested that TLE3 promotes memory B cell development</span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><sup style="font-size:0.6em">[1]</sup></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"> and is involved in the maintenance of intestinal immune homeostasis</span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><sup style="font-size:0.6em">[2]</sup></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">. One study also found that TLE3 expression was significantly increased in patients with Sheehan&rsquo;s syndrome compared to controls</span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><sup style="font-size:0.6em">[3]</sup></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">.</span></span></span></span></span></span></p>

<p style="line-height:1.38"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">TLE3 was found to have a protective role in lung cancer, in line with the genes we have previously presented (Figure 1).</span></span></span></span></span></span></p>

<p><br />
&nbsp;</p>

<p style="text-align:center"><img alt="" height="452" src="https://lh7-us.googleusercontent.com/yh-bxhMDw_X9TKMRKysTaRcWKk0BY2aECdJ9v6Tej43y66e3ueeg9ynU_gRQ14HZSFSmotYBkJUETbjkqNcwQeuB4bWlts7iwrzM75tlWwTNgJ3fueLA-XUFwptcP0eeMyQeOKA6HmDeQ8fT1DbOl8E" width="441" /></p>

<p style="line-height:1.38; text-align:center"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:italic"><span style="text-decoration:none">Figure 1. Survival curves for patients with high and low expression of TLE3 (<a href="http://kmplot.com/">KMplot</a></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:italic"><span style="text-decoration:none">).</span></span></span></span></span></span></p>

<p style="line-height:1.38"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">This overall survival trend is even stronger for females, as depicted in Figure 2.</span></span></span></span></span></span></p>

<p style="line-height:1.38; text-align:center"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><span style="border:none"><span style="display:inline-block"><span style="overflow:hidden"><span style="width:480px"><span style="height:480px"><img alt="" height="480" src="https://lh7-us.googleusercontent.com/00B8n-lgY59h_YPOd3CNoISjlWtkzqOgVuoIDU4Tzjss59xNlVBHSWRdhF7pwxSh7xoIDBpFUn-9w8Gq94jwbSoqJ4aw1KZJHwaaufwGM1nRRzeN_EUQnWcu1q_406P6L9Xyj4TCkz3PwbwLuO0ErCg" width="480" /></span></span></span></span></span></span></span></span></span></span></span></p>

<p style="line-height:1.38; text-align:center"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:italic"><span style="text-decoration:none">Figure 2. Survival curves for female lung cancer patients with high and low expression of TLE3 (<a href="http://kmplot.com/">KMplot</a>)</span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:italic"><span style="text-decoration:none">.</span></span></span></span></span></span></p>

<p style="line-height:1.38"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">We investigated further to see whether TLE3 expression was also associated with other cancers. As shown in Figure 3, comparing cancer to normal tissue, TLE3 is differentially expressed across most cancers (highlighted with red font). Within the literature, TLE3 expression has been associated with melanoma</span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><sup style="font-size:0.6em">[4]</sup></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">, rhabdomyosarcoma</span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><sup style="font-size:0.6em">[5]</sup></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">, ovarian cancer responsiveness to treatment</span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><sup style="font-size:0.6em">[6]</sup></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">, breast cancer prognosis</span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><sup style="font-size:0.6em">[7] </sup></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">and responsiveness to treatment</span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><sup style="font-size:0.6em">[8]</sup></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">.</span></span></span></span></span></span></p>

<p style="line-height:1.38; text-align:center"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><span style="border:none"><span style="display:inline-block"><span style="overflow:hidden"><span style="width:646px"><span style="height:229px"><img alt="" height="229" src="https://lh7-us.googleusercontent.com/GQrqptdhJBtiQJAUFzJNtwnV_g5n1RjZLX3vw91LbenBTTjeYX2wENrjsLGZ0-ql5nw-q4GOEOJXB9wRvf_M73FvwusRNxBTDBL3HO8U5MkcBbHz_6NaIrUwIA3ArRMtCOVbdTErmg7AvkgdYJ_yrGc" style="margin-left:-5px" width="651.4103852596315" /></span></span></span></span></span></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:italic"><span style="text-decoration:none">Figure 3. </span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#161616"><span style="background-color:#ffffff"><span style="font-weight:400"><span style="font-style:italic"><span style="text-decoration:none">Expression of TLE3 in normal and cancer tissue for multiple cancer types. Red text represents a significant difference between expression in cancer tissue compared with normal tissue (<a href="https://tnmplot.com/analysis/">TNMplot</a></span></span></span></span></span></span></span><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#161616"><span style="background-color:#ffffff"><span style="font-weight:400"><span style="font-style:italic"><span style="text-decoration:none">).</span></span></span></span></span></span></span></p>

<p style="line-height:1.38"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">If you have any questions or comments, please leave them in <a href="https://www.worldcommunitygrid.org/forums/wcg/viewthread_thread,46363">this thread</a> for us to answer!</span></span></span></span></span></span></p>

<p style="line-height:1.38"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">WCG Team</span></span></span></span></span></span></p>

<p style="line-height:1.38"><strong>References</strong></p>

<ol>
	<li style="line-height: 1.38;"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Laidlaw BJ, Duan L, Xu Y, Vazquez SE, Cyster JG. The transcription factor Hhex cooperates with the corepressor Tle3 to promote memory B cell development. Nat Immunol. 2020 Sep;21(9):1082-1093. doi: 10.1038/s41590-020-0713-6. Epub 2020 Jun 29. PMID: 32601467; PMCID: PMC7442689.</span></span></span></span></span></span></li>
	<li style="line-height: 1.38;"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Li X, Zhang B, Zhang X, Yu S, Xue HH, Hu X. TLE3 and TLE4-coordinated colonic macrophage-CD4+ T cell crosstalk maintains intestinal immune homeostasis. Mucosal Immunol. 2023 Feb;16(1):50-60. doi: 10.1016/j.mucimm.2022.12.005. Epub 2023 Jan 2. PMID: 36801171.</span></span></span></span></span></span></li>
	<li style="line-height: 1.38;"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Diri H, Sener EF, Bayram F, Dundar M, Simsek Y, Baspinar O, Zararsiz G. Genetic disorders of pituitary development in patients with Sheehan&rsquo;s synfrome. Acta Endocrinol (Buchar). 2016 Oct-Dec;12(4):413-417. doi: 10.4183/aeb.2016.413. PMID: 31149124; PMCID: PMC6535245.</span></span></span></span></span></span></li>
	<li style="line-height: 1.38;"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Ogawa M, Yaginuma T, Nakatomi C, Nakajima T, Tada-Shigeyama Y, Addison WN, Urata M, Matsubara T, Watanabe K, Matsuo K, Sato T, Honda H, Hikiji H, Watanabe S, Kokabu S. Transducin-like enhancer of split 3 regulates proliferation of melanoma cells via histone deacetylase activity. Oncotarget. 2019 Jan 8;10(3):404-414. doi: 10.18632/oncotarget.26552. PMID: 30719233; PMCID: PMC6349449.</span></span></span></span></span></span></li>
	<li style="line-height: 1.38;"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Kalita B, Sahu S, Bharadwaj A, Panneerselvam L, Martinez-Cebrian G, Agarwal M, Mathew SJ. The Wnt-pathway corepressor TLE3 interacts with the histone methyltransferase KMT1A to inhibit differentiation in Rhabdomyosarcoma. Oncogene. 2024 Feb;43(7):524-538. doi: 10.1038/s41388-023-02911-3. Epub 2024 Jan 4. PMID: 38177411.</span></span></span></span></span></span></li>
	<li style="line-height: 1.38;"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Ring BZ, Murali R, Soslow RA, Bowtell DDL, Fereday S, deFazio A, Traficante N, Kennedy CJ, Brand A, Sharma R, Harnett P, Samimi G; Australian Ovarian Cancer Study. Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort Study. Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):680-688. doi: 10.1158/1055-9965.EPI-17-1101. Epub 2018 Mar 12. PMID: 29531130; PMCID: PMC5984690.</span></span></span></span></span></span></li>
	<li style="line-height: 1.38;"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Roboto,sans-serif"><span style="color:#212121"><span style="background-color:#ffffff"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Anstine LJ, Majmudar PR, Aponte A, Singh S, Zhao R, Weber-Bonk KL, Abdul-Karim FW, Valentine M, Seachrist DD, Grennel-Nickelson KE, Cuellar-Vite L, Sizemore GM, Sizemore ST, Webb BM, Thompson CL, Keri RA. TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis. Cancer Res. 2023 Apr 4;83(7):997-1015. doi: 10.1158/0008-5472.CAN-22-3133. PMID: 36696357; PMCID: PMC10089698.</span></span></span></span></span></span></span></li>
	<li style="line-height: 1.38;"><span style="font-size:12pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Roboto,sans-serif"><span style="color:#212121"><span style="background-color:#ffffff"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Kashiwagi S, Fukushima W, Asano Y, Goto W, Takada K, Noda S, Takashima T, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer. BMC Cancer. 2017 Aug 31;17(1):604. doi: 10.1186/s12885-017-3598-5. PMID: 28859615; PMCID: PMC5580315.</span></span></span></span></span></span></span></li>
</ol>
</span>
	        </section>
            
            
            
	        
	        
	        
	        
	    </article>
    </div>
</main>

	                    </div>
	                    </div>
	                </div>
	            </div>
            </div>
        </div>
        <div id="footer"></div>
    </div>
    
    <script src="/static/js/runtime-main.eec01e85.js">
</script>
<script src="/static/js/2.2593f09a.chunk.js">
</script>
<script src="/static/js/main.859d1bf2.chunk.js">
</script>

    
    




<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-P7SR87"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-P7SR87');</script>



<script>
wcg_init();
</script>
</body>
</html>
